Concepedia

Carleen Klumpp‐Thomas

CK

Statistics

Publications

53

Citations

2.9K

H-Index

27

Active since

2016

Affiliations

National Center for Advancing Translational Sciences(Current)

National Institutes of Health

National Cancer Institute

Frederick National Laboratory for Cancer Research

National Institute of Allergy and Infectious Diseases

Carleen Klumpp‐Thomas is an author at National Center for Advancing Translational Sciences specializing in pharmacology, drug discovery, and medicine.

ORCID

Publications per year

2016–2025

53

Publications

53

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening

Grant L. Lin, Kelli M. Wilson, Michele Ceribelli et al. · Science Translational Medicine · 2019 · 258 citations · Full text

, , +17

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening

Wei Zhu, Miao Xu, Catherine Z. Chen et al. · ACS Pharmacology & Translational Science · 2020 · 225 citations · Full text

, , +14

Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses

Jennifer Hicks, Carleen Klumpp‐Thomas, Heather Kalish et al. · Journal of Clinical Immunology · 2021 · 192 citations · Full text

, , +12

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse et al. · Cancer Cell · 2021 · 177 citations · Full text

, , +14

Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

Carleen Klumpp‐Thomas, Heather Kalish, Matthew Drew et al. · Nature Communications · 2021 · 165 citations · Full text

, , +15

1–5 of 53